The Christian Science Monitor Daily for August 22, 2022
Rethink the news: Reducing news to hard lines and side-taking leaves a lot of the story untold. Progress comes from challenging what we hear and considering different views.
Stay updated with breaking news from Longitudinal Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rethink the news: Reducing news to hard lines and side-taking leaves a lot of the story untold. Progress comes from challenging what we hear and considering different views.
Your quick thoughts on now that we have got longitudinal data on vaccine doc they're not that impressive it is getting uglier at this point. >> that's right. so unfortunately, and i'm sorry to say this but the wheels are kind of coming off the vaccine bus, and what we're seeing is a decline in vaccine efficacy within months of the initial dose or doses. and then a decline in efficacy with boosters that happen even faster so you get an initial kind of recovery of protection with the boosters but that's gone within six to eight weeks. and so you can't sort of booster your way ow this problem. we...
We have got longitudinal data on vaccine doc they're not that impressive it is getting uglier at this point. >> that's right. so unfortunately, and i'm sorry to say this but the wheels are kind of coming off the vaccine bus, and what we're seeing is a decline in vaccine efficacy within months of the initial dose or doses. and then a decline in efficacy with boosters that happen even faster so you get an initial kind of recovery of protection with the boosters but that's gone within six to eight weeks. and so you can't sort of booster your way ow this problem. we're also seeing emerging evidenc...
We have got longitudinal data on vaccine doc they're not that impressive it is getting uglier at this point. >> that's right. so unfortunately, and i'm sorry to say this but the wheels are kind of coming off the vaccine bus, and what we're seeing is a decline in vaccine efficacy within months of the initial dose or doses. and then a decline in efficacy with boosters that happen even faster so you get an initial kind of recovery of protection with the boosters but that's gone within six to eight weeks. and so you can't sort of booster your way ow this problem. we're also seeing emerging evidenc...
This report has been written for Young Lives' work capturing methodological learning from our 20 year longitudinal study